Skip to content
stoqly

RenaissanceRe

RNR NYSE Reinsurance Financials FY2016–FY2025

RenaissanceRe's revenue rose 9.9% to $12.8 billion in fiscal 2025. Its net margin was 20.9%, up from 16.0% a year earlier. It paid out $1.7 billion in dividends and buybacks. The diluted share count fell 9.5%.

Last close · Oct 23, 2026

$352.60

2.8%
Value it Compare
Revenue Total sales reported in the income statement.
$12.8B
9.9% vs prior year
Operating margin Operating income as a share of revenue.
—
Net income Profit after all expenses, interest and tax.
$2.7B
43.4%
Free cash flow Cash from operations minus capital spending.
—
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
54.2%
0.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$14.6B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
6.3x

What RenaissanceRe does

No business description yet.

Legal name
RENAISSANCERE HOLDINGS LTD
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0000913144-26-000012
0000913144

Revenue and margins

RenaissanceRe had $12.8B of revenue in fiscal 2025, up 9.9% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 19.3% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.

Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

RenaissanceRe returned $1.7B to shareholders in fiscal 2025. The diluted share count fell 9.5%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value RenaissanceRe yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of $4.1B and divides by 46.5M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 6.3x · peers 10.3x · sector 13.7x.

Balance sheet

Cash, debt and the ratios that show how comfortably RenaissanceRe can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $7.2B$5.9B$6.5B$6.2B$6.5B
Debt incl. finance leases $1.2B$1.2B$2.0B$1.9B$2.3B
Net debt / EBITDA ——−1.5x−1.3x−1.0x
Debt / equity 0.2x0.2x0.2x0.2x0.2x
Interest coverage −1.4x−24.2x43.5x32.9x34.2x
Total assets $34.0B$36.6B$49.0B$50.7B$53.8B
Total liabilities $23.8B$26.7B$33.5B$33.2B$34.6B
Shareholders' equity $6.6B$5.3B$9.5B$10.6B$11.6B
Net debt (− = net cash) −$6.0B−$4.7B−$4.5B−$4.3B−$4.1B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$16.2M

3 insiders

Of sales under plans

78%

$12.6M

DateInsiderTradeSharesPriceValueFiling
Sep 3, 2026 Ross CurtisEVP,Chief Portfolio Officer Sold plan 9,623 $337.60 $3.2M Form 4
Aug 26, 2026 Ross CurtisEVP,Chief Portfolio Officer Sold plan 377 $335.00 $0.1M Form 4
Aug 24, 2026 Ross CurtisEVP,Chief Portfolio Officer Sold plan 5,000 $330.00 $1.7M Form 4
Aug 17, 2026 Ross CurtisEVP,Chief Portfolio Officer Sold plan 5,000 $325.00 $1.6M Form 4
Jul 28, 2026 Robert QutubEVP, Chief Financial Officer Sold 5,000 $333.03 $1.7M Form 4
May 18, 2026 Carol P SandersDirector Sold 1,479 $297.36 $0.4M Form 4
Feb 6, 2026 Robert QutubEVP, Chief Financial Officer Sold 5,000 $305.75 $1.5M Form 4
Feb 5, 2026 Ross CurtisEVP,Chief Portfolio Officer Sold plan 5,000 $305.00 $1.5M Form 4
Feb 4, 2026 Ross CurtisEVP,Chief Portfolio Officer Sold plan 15,000 $295.00 $4.4M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✕ ✓
Cash from operations exceeds net income ✕ ✓ ✓
Debt fell relative to assets ✕ ✓ ✕
Current ratio rose — — —
Share count didn't rise ✕ ✕ ✓
Gross margin rose — — —
Revenue rose relative to assets ✓ ✕ ✓
F-score — / 9— / 9— / 9
Accruals ratio 1.5%−4.6%−1.9%
Altman Z'' ———

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
RenaissanceRe RNR $14.6B 9.9% — — 54.2% 6.3x —
Everest Group EG $15.5B 1.2% — — — 8.4x — Compare →
Reinsurance Group of America RGA $17.4B 7.2% — — — 11.6x — Compare →
MGIC Investment MTG $6.1B 0.5% — 70.2% — 9.0x — Compare →
Assurant AIZ $14.2B 7.9% — 12.5% 17.5% 13.6x — Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $1.7B $2.1B $2.1B $4.2B $5.2B $5.3B $5.1B $9.1B $11.7B $12.8B
Interest expense $42.1M $44.2M $47.1M $58.4M $50.5M $47.5M $48.3M $73.2M $93.8M $121M
Pretax income $630M −$328M $263M $968M $996M −$114M −$1.2B $3.1B $3.0B $4.0B
Income tax $0.3M $26.5M −$6.3M $17.2M $2.9M −$10.7M −$59.0M −$510M $32.6M $396M
Net income $503M −$222M $227M $749M $762M −$40.2M −$1.1B $2.6B $1.9B $2.7B
Diluted EPS $11.43 −$6.15 $4.91 $16.29 $15.31 −$1.57 −$25.50 $52.27 $35.21 $56.03
Diluted shares 0.04B 0.04B 0.04B 0.04B 0.05B 0.05B 0.04B 0.05B 0.05B 0.05B
Cash flow
Cash from operations $485M $1.0B $1.2B $2.1B $2.0B $1.2B $1.6B $1.9B $4.2B $3.7B
Depreciation and amortization $29.3M $31.2M $0.1M −$59.0M $16.7M −$21.0M −$26.9M −$135M $259M −$14.1M
Stock-based compensation $47.4M $37.2M $35.7M $41.4M $43.7M $40.0M $45.2M $60.3M $71.4M $77.5M
Acquisitions $0.0M $0.0M $0.0M $276M $0.0M $0.0M $0.0M $2.4B $0.0M $0.0M
Share buybacks $309M $189M $0.0M $0.0M $62.6M $1.0B $167M $0.0M $667M $1.6B
Dividends paid $51.6M $51.4M $52.8M $59.4M $68.5M $67.8M $64.7M $75.1M $80.8M $74.8M
Dividends and buybacks $361M $240M $52.8M $59.4M $131M $1.1B $231M $75.1M $748M $1.7B
Balance sheet
Cash and short-term investments $1.8B $2.4B $3.7B $5.9B $6.7B $7.2B $5.9B $6.5B $6.2B $6.5B
Total debt $949M $990M $991M $1.4B $1.1B $1.2B $1.2B $2.0B $1.9B $2.3B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $22.5M $22.0M $21.5M $21.0M $20.4M
Inventory $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Total assets $12.4B $15.2B $18.7B $26.3B $30.8B $34.0B $36.6B $49.0B $50.7B $53.8B
Total liabilities $6.3B $9.5B $11.6B $17.3B $19.9B $23.8B $26.7B $33.5B $33.2B $34.6B
Shareholders' equity $4.9B $4.4B $5.0B $6.0B $7.6B $6.6B $5.3B $9.5B $10.6B $11.6B
Margins
EBITDA margin 40.6% −12.0% 14.9% 23.0% 20.6% −1.7% −23.7% 33.4% 28.6% 32.1%
Net margin 29.1% −10.6% 11.0% 17.8% 14.7% −0.8% −21.0% 28.0% 16.0% 20.9%
Returns
Return on capital 16.8% −6.4% 11.5% — — — — — 54.4% 54.2%
Return on equity 10.5% −4.8% 4.8% 13.6% 11.3% −0.6% −17.8% 34.7% 18.7% 24.2%
Return on assets 4.2% −1.6% 1.3% 3.3% 2.7% −0.1% −3.0% 6.0% 3.8% 5.1%
Growth
Revenue growth 14.0% 21.8% −1.4% 102.5% 23.1% 2.0% −4.1% 80.5% 28.0% 9.9%
Net income growth 16.6% −144.2% — 229.3% 1.8% −105.3% — — −27.0% 43.4%
EPS growth 23.2% −153.8% — 231.8% −6.0% −110.3% — — −32.6% 59.1%
Share count change −4.5% −4.1% −0.3% 8.6% 9.3% −0.0% −8.8% 10.6% 7.8% −9.5%
Financial health
Net debt / EBITDA −1.2x — −8.7x −4.7x −5.3x — — −1.5x −1.3x −1.0x
Debt / equity 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x 0.2x
Interest coverage 16.0x −6.4x 6.6x 17.6x 20.7x −1.4x −24.2x 43.5x 32.9x 34.2x
Capital allocation
Stock comp / revenue 2.7% 1.8% 1.7% 1.0% 0.8% 0.8% 0.9% 0.7% 0.6% 0.6%
Quality scores
Accruals ratio 0.2% −9.1% −5.9% −6.2% −4.3% −3.9% −7.6% 1.5% −4.6% −1.9%

Source: SEC EDGAR XBRL filings (CIK 0000913144). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open